These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 4644164)

  • 21. [Autopsy case of multiple myeloma with cryo-Bence Jones protein].
    Hirai H; Doi I; Kawai T
    Naika; 1969 Mar; 23(3):585-91. PubMed ID: 5783356
    [No Abstract]   [Full Text] [Related]  

  • 22. Hyperviscosity syndrome in multiple myeloma.
    Lancet; 1973 Feb; 1(7799):359-60. PubMed ID: 4121944
    [No Abstract]   [Full Text] [Related]  

  • 23. [Light-chain myeloma and osteomalacia].
    Gardais J; Gardais B; Drouet M; Simard C; Perreau P
    Rev Rhum Mal Osteoartic; 1972 May; 39(5):386-95. PubMed ID: 4216070
    [No Abstract]   [Full Text] [Related]  

  • 24. Double spike in myeloma serum due to retention of light chains.
    Zinneman HH; Seal US
    Arch Intern Med; 1969 Jul; 124(1):77-80. PubMed ID: 4978219
    [No Abstract]   [Full Text] [Related]  

  • 25. Leukemic form of immunocytic dyscrasia (plasma cell leukemia). A study of ten cases and a review of the literature.
    Pruzanski W; Platts ME; Ogryzlo MA
    Am J Med; 1969 Jul; 47(1):60-74. PubMed ID: 4183356
    [No Abstract]   [Full Text] [Related]  

  • 26. Hyperviscosity in IgG myeloma: detection and treatment in community medical facilities.
    Seward CW; Osterland CK
    Tex Med; 1974 Mar; 70(3):63-5. PubMed ID: 4818033
    [No Abstract]   [Full Text] [Related]  

  • 27. [Multiple myeloma with two serum M components (IgG-lambda, IgA-kappa) and two Bence Jones proteins (lambda, kappa)--evidence for two distinct monoclonal cell populations and effects of chemotherapy and plasmapheresis].
    Wakui H; Nishimura S; Akihama T; Imai H; Takahashi T; Kuwayama A; Nakamoto Y; Miura AB
    Nihon Naika Gakkai Zasshi; 1984 Dec; 73(12):1811-7. PubMed ID: 6442730
    [No Abstract]   [Full Text] [Related]  

  • 28. IgG myeloma, Sia test, and serum hyperviscosity.
    Rubies-Prat J; Gallart MT; Frison JC; Caralps A; Schwartz S; Bacardi R
    Acta Haematol; 1974; 52(2):107-11. PubMed ID: 4214602
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasmacytic myeloma. A study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients.
    Carbone PP; Kellerhouse LE; Gehan EA
    Am J Med; 1967 Jun; 42(6):937-48. PubMed ID: 6027163
    [No Abstract]   [Full Text] [Related]  

  • 30. IgG myeloma cryoglobulin with antistreptolysin activity.
    Seligmann M; Danon F; Basch A; Bernard J
    Nature; 1968 Nov; 220(5168):711-2. PubMed ID: 5688148
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cryo-Bence Jones protein. First case in Japan].
    Kawai T; Tadano J
    Igaku To Seibutsugaku; 1967 May; 74(5):251-7. PubMed ID: 5624243
    [No Abstract]   [Full Text] [Related]  

  • 32. IgD plasma cell neoplasia: clinical manifestations and characteristic features.
    Pruzanski W; Rother I
    Can Med Assoc J; 1970 May; 102(10):1061-5. PubMed ID: 5000054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of IgG lambda myeloma associated with hyperviscosity syndrome. A speculative mechanism of hyperviscosity syndrome with relative low serum viscosity (author's transl)].
    Katsuki A; Shimazaki C; Osamura K; Nakanishi S; Kayawake S; Sasaki T; Murano K; Nakata T; Nishio A; Hosoda M; Haruyama H; Matsushima K; Ijichi H; Isemura T
    Rinsho Ketsueki; 1979 Jun; 20(6):658-66. PubMed ID: 112269
    [No Abstract]   [Full Text] [Related]  

  • 34. Light chain disease associated with the hyperviscosity syndrome.
    Khan P; Roth MS; Keren DF; Foon KA
    Cancer; 1987 Nov; 60(9):2267-8. PubMed ID: 3125955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Importance of the diagnosis of monoclonal dysglobulinemia in medical practice].
    Dorr R; Mateja F; Denave L
    Sem Hop; 1969 Dec; 45(51):3257-63. PubMed ID: 4189409
    [No Abstract]   [Full Text] [Related]  

  • 36. [Acute renal failure revealing Kahler's disease. Recovery with a 13-month follow-up. Value of peritoneal dialysis].
    Péquignot H; Guerre J; Van Amerongen P; Nazarian G; Christoforov B
    Sem Hop; 1969 May; 45(25):1743-6. PubMed ID: 4308465
    [No Abstract]   [Full Text] [Related]  

  • 37. Fragments of Bence-Jones proteins: products of degradation or of synthesis by plasmocytoma cells?
    Wetter O
    Klin Wochenschr; 1970 Apr; 48(8):482-4. PubMed ID: 5534829
    [No Abstract]   [Full Text] [Related]  

  • 38. Growth rates and responses to treatment in human myelomatosis.
    Hobbs JR
    Br J Haematol; 1969 Jun; 16(6):607-17. PubMed ID: 4184691
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficient removal of abnormal immunoglobulin G from plasma of a multiple myeloma patient. Description of a new method for treatment of the hyperviscosity syndrome.
    Ray PK; Besa E; Idiculla A; Rhoads JE; Bassett JG; Cooper DR
    Cancer; 1980 May; 45(10):2633-8. PubMed ID: 6155195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias.
    Willrich MA; Katzmann JA
    Clin Chem Lab Med; 2016 Jun; 54(6):907-19. PubMed ID: 26509779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.